Recombinant Human ATP-binding cassette sub-family D member 3 (ABCD3)

Shipped with Ice Packs
In Stock

Description

Molecular Characterization of Recombinant Human ABCD3

Recombinant human ABCD3 (ATP-binding cassette sub-family D member 3) is a transmembrane protein expressed in heterologous systems for research purposes. Key molecular attributes include:

PropertyValue
Gene NameABCD3
Protein NameATP-binding cassette sub-family D member 3, PMP70, PXMP1
UniProt IDP28288
Chromosomal Location1p21.3
Protein Length659 amino acids
Molecular Weight75.5 kDa
Transmembrane DomainsMulti-pass membrane protein

ABCD3 belongs to the ALD subfamily of ABC transporters and functions as a half-transporter, requiring dimerization with a partner protein (e.g., ABCD1/2) for full activity . It is critical for peroxisomal fatty acid β-oxidation, transporting long-chain and branched-chain fatty acyl-CoA esters .

Expression Systems and Recombinant Production

Recombinant ABCD3 is produced using diverse systems to optimize yield and functionality:

Expression SystemHostKey Features
Mammalian CellsHEK293FNative membrane integration, high authenticity
Cell-FreeWheat GermSoluble expression, non-tagged
BacterialE. coliCost-effective, scalable for structural studies
Chimeric ConstructsC. elegans PMP2/hABCD3Enhanced expression yield (~10x), structural stability

Recent advancements include chimeric ABCD3 (chABCD3), combining the N-terminal segment of C. elegans PMP2 with human core domains to improve solubility and crystallization .

Disease Associations

ABCD3 mutations cause severe metabolic disorders:

  • Zellweger Syndrome: Autosomal recessive peroxisome biogenesis disorder linked to impaired fatty acid import .

  • Bile Acid Synthesis Defects: Congenital deficiencies in bile acid production .

Role in Cancer Prognosis

Low ABCD3 mRNA expression correlates with poor survival in colorectal cancer (CRC), suggesting its potential as a diagnostic/prognostic biomarker .

Research Applications and Challenges

ApplicationDetails
Fatty Acid Transport StudiesUsed to model BCFA-CoA translocation and ATP hydrolysis kinetics
Cryo-EM Structural AnalysisChimeric ABCD3 enables high-resolution visualization of transport states
Therapeutic TargetingInhibiting ABCD3 may modulate lipid metabolism in metabolic disorders

Challenges:

  • Heterodimerization: Functional studies require co-expression with partner proteins (e.g., ABCD2) .

  • Post-Translational Modifications: Limited data on phosphorylation or ubiquitination impacting activity .

Product Specs

Buffer
For liquid delivery forms, the default storage buffer is a Tris/PBS-based buffer containing 5%-50% glycerol. For lyophilized powder delivery forms, the buffer used before lyophilization is a Tris/PBS-based buffer containing 6% Trehalose.
Form
Liquid or Lyophilized powder
Please note: We will prioritize shipping the format that is currently in stock. However, if you have a specific format requirement, please indicate it in your order notes, and we will accommodate your request.
Lead Time
Delivery time may vary depending on the purchase method or location. Please consult your local distributors for specific delivery time information.
Notes
Repeated freezing and thawing is not recommended. For optimal results, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents settle to the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We suggest adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%, which can be used as a reference.
Shelf Life
Shelf life can vary depending on factors such as storage conditions, buffer components, storage temperature, and the inherent stability of the protein itself. Generally, liquid forms have a shelf life of 6 months at -20°C/-80°C, while lyophilized forms have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
N-terminal 10xHis-tagged
Datasheet & Coa
Please contact us to get it.
Expression Region
1-659aa
Mol. Weight
81.5 kDa
Protein Length
Full Length
Purity
Greater than 85% as determined by SDS-PAGE.
Research Area
Metabolism
Source
in vitro E.coli expression system
Species
Homo sapiens (Human)
Target Names
ABCD3
Target Protein Sequence
MAAFSKYLTARNSSLAGAAFLLLCLLHKRRRALGLHGKKSGKPPLQNNEKEGKKERAVVDKVFFSRLIQILKIMVPRTFCKETGYLVLIAVMLVSRTYCDVWMIQNGTLIESGIIGRSRKDFKRYLLNFIAAMPLISLVNNFLKYGLNELKLCFRVRLTKYLYEEYLQAFTYYKMGNLDNRIANPDQLLTQDVEKFCNSVVDLYSNLSKPFLDIVLYIFKLTSAIGAQGPASMMAYLVVSGLFLTRLRRPIGKMTITEQKYEGEYRYVNSRLITNSEEIAFYNGNKREKQTVHSVFRKLVEHLHNFILFRFSMGFIDSIIAKYLATVVGYLVVSRPFLDLSHPRHLKSTHSELLEDYYQSGRMLLRMSQALGRIVLAGREMTRLAGFTARITELMQVLKDLNHGKYERTMVSQQEKGIEGVQVIPLIPGAGEIIIADNIIKFDHVPLATPNGDVLIRDLNFEVRSGANVLICGPNGCGKSSLFRVLGELWPLFGGRLTKPERGKLFYVPQRPYMTLGTLRDQVIYPDGREDQKRKGISDLVLKEYLDNVQLGHILEREGGWDSVQDWMDVLSGGEKQRMAMARLFYHKPQFAILDECTSAVSVDVEGYIYSHCRKVGITLFTVSHRKSLWKHHEYYLHMDGRGNYEFKQITEDTVEFGS
Note: The complete sequence including tag sequence, target protein sequence and linker sequence could be provided upon request.
Uniprot No.

Target Background

Function
Recombinant Human ATP-binding cassette sub-family D member 3 (ABCD3) is an ATP-dependent transporter belonging to the ATP-binding cassette (ABC) family. It exhibits broad substrate specificity and catalyzes the transport of long-chain fatty acids (LCFA)-CoA, dicarboxylic acids-CoA, long-branched-chain fatty acids-CoA, and bile acids from the cytosol to the peroxisome lumen, where they undergo beta-oxidation. Additionally, ABCD3 possesses fatty acyl-CoA thioesterase and ATPase activities. It likely hydrolyzes fatty acyl-CoAs into free fatty acids prior to their ATP-dependent transport into peroxisomes. Therefore, ABCD3 plays a crucial role in regulating LCFA and energy metabolism, particularly in the degradation and biosynthesis of fatty acids through beta-oxidation.
Gene References Into Functions
  1. ABCD1 and ABCD2 are involved in the transport of long and very long chain fatty acids (VLCFA) or their CoA-derivatives into peroxisomes, exhibiting distinct substrate specificities. In contrast, ABCD3 is involved in the transport of branched chain acyl-CoA into peroxisomes. ABCD4 is believed to participate in the transport of vitamin B12 from lysosomes into the cytosol. PMID: 27766264
  2. Studies demonstrate that ACBD3 can recruit PI4KB to model membranes and redirect PI4KB to cellular membranes where it is not naturally found. Furthermore, findings indicate that ACBD3 regulates the enzymatic activity of PI4KB kinase through membrane recruitment rather than allosteric mechanisms. PMID: 27009356
  3. The N-terminal motif of PMP70 inhibits cotranslational targeting to the endoplasmic reticulum. PMID: 26711236
  4. Elevated ABCD3 expression correlates with Gleason Score. PMID: 25802834
  5. Deficiency of peroxisomal ABCD3 results in a defect in bile acid biosynthesis. PMID: 25168382
  6. It is hypothesized that human ABCD3 plays a role in the oxidation of dicarboxylic acids and acts as a buffering mechanism for fatty acids that overflow from the mitochondrial beta-oxidation system. PMID: 24333844
  7. Research investigates the organelle-targeting properties of N-terminal portions of peroxisomal PMP70, examining the amino acid sequence and domain structure of the human form. PMID: 20007743
  8. Testosterone metabolites do not alter the expression of ABCD3 mRNA in fibroblasts from X-linked adrenoleukodystrophy patients. PMID: 17602313
  9. ALDRP interacts with PMP70. This interaction occurs through the ALDRP C-terminus [374-740] and the PMP70 C-terminus [338-659]. This interaction has been demonstrated using human PMP70 and mouse ALDRP. PMID: 10551832
  10. ALDP interacts with PMP70. This interaction occurs via the C-terminus of ALDP [361-745] and the C-terminus of PMP70 [338-659]. ALDP mutations P484R and R591Q abolish this interaction. PMID: 10551832
  11. PMP70 (ABCD3) forms homodimers via the carboxy terminal half [338-659]. PMID: 10551832

Show More

Hide All

Database Links

HGNC: 67

OMIM: 170995

KEGG: hsa:5825

STRING: 9606.ENSP00000359233

UniGene: Hs.700576

Involvement In Disease
Congenital bile acid synthesis defect 5 (CBAS5)
Protein Families
ABC transporter superfamily, ABCD family, Peroxisomal fatty acyl CoA transporter (TC 3.A.1.203) subfamily
Subcellular Location
Peroxisome membrane; Multi-pass membrane protein.

Q&A

What is ATP-binding Cassette Sub-Family D Member 3 (ABCD3) and what are its key molecular characteristics?

ATP-binding Cassette Sub-Family D Member 3 (ABCD3), also identified as PMP70, is a peroxisomal membrane protein that belongs to the ABC transporter family. It is characterized by the following molecular properties:

  • Molecular Weight: The observed molecular weight is approximately 70 kDa .

  • Gene Identification: ABCD3 is encoded by the gene with GeneID 5825 and is registered in multiple databases including UniProt (Primary AC: P28288), OMIM (170995), and NCBI (Accession: NP_002849.1, NM_002858) .

  • Protein Structure: ABCD3 contains six transmembrane helices (TMs) and exhibits a domain-swapped arrangement when assembled as a dimer .

  • Functional Role: ABCD3 is primarily responsible for the transport of long-chain fatty acid-CoA (LCFA-CoA) across the peroxisomal membrane, playing a crucial role in lipid metabolism and peroxisomal function .

The protein features structural elements that are essential for its transport function, including transmembrane domains (TMDs) that form substrate binding cavities and nucleotide-binding domains (NBDs) that hydrolyze ATP to power the transport process .

How does ABCD3 differ functionally from other members of the ABCD subfamily?

The ABCD subfamily consists of four members with distinct functional roles and localizations:

ABCD ProteinAlternative NameCellular LocalizationPrimary Substrate Specificity
ABCD1ALDPPeroxisomesVery-long-chain fatty acids (VLCFAs)
ABCD2ALDRPPeroxisomesVLCFAs (different specificity from ABCD1)
ABCD3PMP70PeroxisomesLong-chain fatty acid-CoA (LCFA-CoA)
ABCD4-LysosomesCobalamin (Vitamin B12)

ABCD3 differs from its subfamily members in several important ways:

  • While ABCD1 and ABCD2 primarily transport very-long-chain fatty acids (VLCFAs) with different specificities, ABCD3 was reported to transport LCFA-CoA .

  • ABCD3 shares the peroxisomal localization with ABCD1 and ABCD2, unlike ABCD4 which is localized to lysosomes .

  • ABCD2 can compensate for the function loss of ABCD1 in certain conditions, suggesting some functional redundancy between these two proteins, whereas ABCD3 has more distinct substrate preferences .

These functional differences highlight the specialized role of ABCD3 in peroxisomal metabolism and underscore the importance of studying each ABCD transporter in its specific cellular context.

What applications are ABCD3 antibodies commonly used for in research?

ABCD3 antibodies serve as valuable tools in multiple research applications, enabling scientists to study the expression, localization, and function of this important peroxisomal transporter. The most common applications include:

ApplicationRecommended DilutionPurpose in ABCD3 Research
ELISA1/20000 - 1/80000Quantitative detection of ABCD3 in biological samples
Western Blot (WB)1/500 - 1/2000Analysis of ABCD3 protein expression levels and molecular weight confirmation
Immunohistochemistry (IHC)1/100 - 1/200Visualization of ABCD3 localization in tissue sections

When using these applications, researchers should note that optimal dilutions/concentrations should be determined experimentally by the end user, as factors such as sample type, detection method, and antibody lot can influence results . The polyclonal antibody described in the search results is generated in rabbits against a recombinant fragment corresponding to amino acids 318-586 of human ABCD3, making it highly specific for human ABCD3 with predicted cross-reactivity with mouse and rat ABCD3 .

What structural characteristics of ABCD3 determine its substrate specificity and transport mechanism?

The structural analysis of ABCD3 reveals several key features that determine its substrate specificity and transport mechanism:

These structural elements work in concert to enable ABCD3 to specifically recognize, bind, and transport LCFA-CoA across the peroxisomal membrane in an ATP-dependent manner.

How do conformational changes in ABCD3 facilitate substrate transport?

ABCD3 undergoes significant conformational changes during its transport cycle, which are essential for substrate binding, translocation, and release:

  • Ligand-Free State: In the absence of substrate, ABCD3 adopts a cytosolic-facing conformation with specific spatial arrangements of its transmembrane helices .

  • Substrate-Bound State: Upon binding of substrates such as C22:0-CoA, conformational changes occur primarily in the transmembrane domains. The distance between TM4 and TM6 changes, reflecting alterations in the substrate binding cavity .

  • ATP-Bound State: Binding of ATP triggers further dramatic conformational changes that facilitate substrate translocation. These changes involve cooperative movements between the transmembrane domains and the nucleotide-binding domains .

The transport cycle involves the extrusion of unknown densities at the crevice of TMDs during substrate loading, as observed in structural studies . When comparing the ligand-free structure with C22:0-CoA-bound and ATP-bound structures, researchers have identified dramatic conformational changes that illustrate the mechanical basis of transport .

These structural transitions create an alternating access mechanism that allows ABCD3 to bind substrates on one side of the membrane, undergo conformational changes, and release substrates on the other side of the membrane, all powered by ATP hydrolysis.

What methodological approaches are most effective for studying ABCD3 transport activity?

Effective study of ABCD3 transport activity requires a combination of biochemical, structural, and functional approaches:

  • Purification and Reconstitution:

    • The protein must be properly purified and reconstituted in a suitable membrane environment to maintain its native activity.

    • As demonstrated in studies, ABCD3 can be reconstituted with a Vmax of approximately 193 ± 8.2 mol Pi min⁻¹ mol⁻¹ protein and a Km value of ~0.17 μM C22:0-CoA .

  • ATP Hydrolysis Assays:

    • Measuring ATP hydrolysis rates provides a quantitative assessment of ABCD3 activity.

    • Wild-type ABCD3 and mutant variants can be compared using standardized ATP hydrolysis assays to identify residues critical for activity .

  • Transport Assays with Radiolabeled or Fluorescent Substrates:

    • Direct measurement of transport using labeled substrates such as C22:0-CoA, C24:0-CoA, and C26:0-CoA.

    • These assays can determine transport kinetics and substrate specificity .

  • Structural Analysis:

    • Cryo-electron microscopy has proven valuable for determining ABCD3 structure in different conformational states .

    • Comparing structures in ligand-free, substrate-bound, and ATP-bound states provides insights into the transport mechanism .

  • Mutational Analysis:

    • Systematic mutation of key residues followed by functional assays helps identify amino acids critical for substrate binding, ATP hydrolysis, or conformational changes .

    • Comparison of wild-type and mutant proteins in transport assays can reveal the importance of specific structural elements .

By combining these approaches, researchers can gain comprehensive insights into ABCD3 transport activity and understand how structural features relate to functional properties.

What are the critical parameters for optimizing ABCD3 antibody applications in experimental protocols?

When designing experiments using ABCD3 antibodies, researchers should consider several critical parameters to ensure optimal results:

ParameterRecommendationJustification
Antibody FormatConsider the lyophilized form with proper reconstitutionThe antibody is supplied in lyophilized form and should be reconstituted in 100 μl of sterile distilled H₂O with 50% glycerol
Storage ConditionsStore at -20°C and avoid repeated freeze/thaw cyclesProper storage maintains antibody integrity and prevents degradation
Dilution OptimizationELISA: 1/20000-1/80000, WB: 1/500-1/2000, IHC: 1/100-1/200Starting dilutions should be optimized for each specific application and sample type
Cross-Reactivity ConsiderationPredicted to react with Mouse and Rat ABCD3When working with non-human samples, consider the predicted cross-reactivity
Buffer CompositionNote presence of 0.02% NaN₃ prior to lyophilizationBuffer components may affect certain applications and should be considered in experimental design
Positive ControlsInclude positive controls expressing known levels of ABCD3Validates antibody performance and provides reference for quantification
Negative ControlsInclude negative controls without primary antibodyEssential for distinguishing specific from non-specific binding

For Western blot applications specifically, researchers should expect to observe ABCD3 at approximately 70 kDa, which corresponds to its observed molecular weight . When preparing samples for immunohistochemistry, optimization of fixation methods and antigen retrieval protocols may be necessary to expose ABCD3 epitopes effectively, particularly given its membrane localization in peroxisomes.

How should researchers analyze and interpret structural data for ABCD3 in comparison with predictive models?

Analyzing and interpreting structural data for ABCD3 requires careful consideration of multiple approaches and potential discrepancies between experimental and predictive models:

  • Comparison Between Cryo-EM Structures and Predicted Models:

    • Recent studies have compared cryo-electron microscopy (cryo-EM) structures with those predicted by AlphaFold (AF) .

    • Researchers should examine structural alignments between experimentally determined structures and predicted models to identify regions of agreement and discrepancy .

  • Conformational State Considerations:

    • Different structural determination methods may capture ABCD3 in different conformational states.

    • Comparison between AF-model and cryo-EM models in different states (e.g., apo state vs. ATP-bound state) provides insights into the accuracy of predictive models across the conformational landscape .

  • Comparative Analysis with Related Transporters:

    • Comparison between ABCD3 and other ABC transporters, such as phosphatidylcholine transporter ABCB4, in three major states of a working cycle (ligand-free, substrate-bound, and ATP-bound states) provides context for interpreting ABCD3-specific structural features .

    • These comparisons can highlight conserved mechanisms versus unique aspects of ABCD3 function.

  • Resolution Considerations:

    • The nominal resolution of the cryo-EM structure at 3.4 Å provides high confidence for most regions, but some regions may have lower local resolution .

    • For instance, the C-terminal helix regions had a local resolution of approximately 4.0 Å, which was not accurate enough to build a complete atomic model .

  • Integration with Functional Data:

    • Structural interpretations are most valuable when integrated with functional data from transport assays and ATP hydrolysis measurements.

    • This integration helps correlate structural features with functional significance .

By carefully considering these factors, researchers can extract meaningful insights from structural data and develop accurate models of ABCD3 function that bridge structural information with physiological relevance.

How can researchers classify and interpret the impact of ABCD3 mutations on protein function?

Understanding the impact of mutations on ABCD3 function requires systematic classification and comprehensive functional analysis. Researchers can approach this using the following framework:

  • Structural Classification of Mutations:
    Based on structural mapping, mutations can be classified into three main groups:

    • Group 1: Mutations affecting residues that line the substrate-binding cavity, likely influencing substrate coordination and delivery .

    • Group 2: Mutations located in other regions of the transmembrane domains (TMDs) that undergo conformational changes during the transport cycle .

    • Group 3: Mutations located on the nucleotide-binding domains (NBDs) that may influence ATP hydrolysis .

  • Functional Assessment Parameters:
    To comprehensively evaluate the impact of mutations, researchers should assess:

    Assessment ParameterMethodologySignificance
    Cellular LocalizationFluorescence microscopy of tagged proteinsDetermines if mutation affects proper targeting to peroxisomes
    Protein Expression LevelWestern blot with GAPDH as loading controlQuantifies impact on protein stability and expression
    ThermostabilityThermal shift assaysMeasures Tm values to assess structural integrity of mutant proteins
    ATP HydrolysisATPase assaysQuantifies ability to hydrolyze ATP, essential for transport function
    Transport ActivityTransport of C22:0-CoA, C24:0-CoA, C26:0-CoADirectly measures functional impact on substrate transport
  • Correlation of Structure-Function Relationships:

    • Mutations in substrate binding regions often directly affect substrate specificity or transport efficiency .

    • Mutations in conformationally important regions may impact the transport cycle without affecting substrate binding .

    • Mutations in NBDs typically affect ATP hydrolysis rates but may also have allosteric effects on substrate binding .

  • Integration with Computational Predictions:

    • Comparison between experimentally determined effects and computational predictions (e.g., from AlphaFold models) can provide additional insights into mutation mechanisms .

    • This approach is particularly valuable for mutations in regions where structural data is limited or of lower resolution.

By applying this comprehensive analytical framework, researchers can gain detailed insights into how specific mutations impact ABCD3 structure and function, potentially leading to new therapeutic strategies for disorders associated with ABCD3 dysfunction.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.